Cargando…

Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape

SARS-CoV-2 variants with enhanced transmissibility represent a serious threat to global health. Here we report machine learning models that can predict the impact of receptor-binding domain (RBD) mutations on receptor (ACE2) affinity, which is linked to infectivity, and escape from human serum antib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makowski, Emily K., Schardt, John S., Smith, Matthew D., Tessier, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223403/ https://www.ncbi.nlm.nih.gov/pubmed/35639784 http://dx.doi.org/10.1371/journal.pcbi.1010160

Ejemplares similares

SARS-CoV-2 Variants, RBD Mutations, Binding Affinity, and Antibody Escape
por: Yang, Lin, et al.
Publicado: (2021)

Identification of key mutations responsible for the enhancement of receptor-binding affinity and immune escape of SARS-CoV-2 Omicron variant
por: Wang, Wei Bu, et al.
Publicado: (2023)

Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening
por: Schardt, John S., et al.
Publicado: (2021)

Co-optimization of therapeutic antibody affinity and specificity using machine learning models that generalize to novel mutational space
por: Makowski, Emily K., et al.
Publicado: (2022)

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern
por: Triveri, Alice, et al.
Publicado: (2021)

Rapid test to assess the escape of SARS-CoV-2 variants of concern
por: Heggestad, Jacob T., et al.
Publicado: (2021)

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
por: Muecksch, Frauke, et al.
Publicado: (2021)

The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
por: Tian, Dandan, et al.
Publicado: (2021)

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

The Route of HIV Escape from Immune Response Targeting Multiple Sites Is Determined by the Cost-Benefit Tradeoff of Escape Mutations
por: Batorsky, Rebecca, et al.
Publicado: (2014)

SARS-CoV-2 variants, spike mutations and immune escape
por: Harvey, William T., et al.
Publicado: (2021)

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
por: Jeong, Bo-Seong, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2023)

Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants
por: Miller, Nathaniel L., et al.
Publicado: (2021)

Use of Sanger protocols to identify variants of concern, key mutations and track evolution of SARS-CoV-2
por: Cabral, Gabriela Bastos, et al.
Publicado: (2022)

Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
por: Engelhart, Emily, et al.
Publicado: (2022)

Molecular strategies for antibody binding and escape of SARS-CoV-2 and its mutations
por: Hendy, Mohamed, et al.
Publicado: (2021)

An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)

SARS-CoV-2 Variants of Concern
por: Choi, Jun Yong, et al.
Publicado: (2021)

In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential
por: Lam, Brandon, et al.
Publicado: (2021)

Digital PCR Discriminates between SARS-CoV-2 Omicron Variants and Immune Escape Mutations
por: Holland, Steven C., et al.
Publicado: (2023)

The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD–ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective
por: Khan, Abbas, et al.
Publicado: (2021)

Position-Specific Enrichment Ratio Matrix scores predict antibody variant properties from deep sequencing data
por: Smith, Matthew D, et al.
Publicado: (2023)

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism
por: Bachmann, Martin F., et al.
Publicado: (2022)

Escape mutations circumvent a tradeoff between resistance to a beta-lactam and resistance to a beta-lactamase inhibitor
por: Russ, Dor, et al.
Publicado: (2020)

SARS-CoV-2 variants, immune escape, and countermeasures
por: Zhang, Yi, et al.
Publicado: (2022)

ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern
por: Tsai, Tsung-I, et al.
Publicado: (2022)

SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
por: Noh, Ji Yun, et al.
Publicado: (2021)

Predicting the mutational drivers of future SARS-CoV-2 variants of concern
por: Maher, M. Cyrus, et al.
Publicado: (2022)

A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern
por: Parray, Hilal Ahmad, et al.
Publicado: (2022)

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
por: Baum, Alina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i2bru2j7l949r4114rt5n21vi2